FDA-Drug2020-09-16Class II
Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, 100 mL bottle when mixed, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-4177-73.
Teva Pharmaceuticals USA
Hazard
Sub-Potent Drug: Out of specification test results for potency (below specification).
Sold states
Nationwide in the U.S. and Puerto Rico.
Affected count
38,487 bottles
Manufactured in
400 Interpace Pkwy, Parsippany, NJ, United States
Products
Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, 100 mL bottle when mixed, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-4177-73.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1566-2020Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief